Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy)

Core Insights - Fresenius Medical Care AG (NYSE: FMS) shares have increased by 32.95% year-over-year ahead of its Q2 2025 earnings results scheduled for August 2025 [1] - The company reported a slight earnings beat in Q1 2025, indicating positive momentum in its financial performance [1] Company Performance - The significant rise in share price reflects investor confidence and market anticipation regarding the company's upcoming earnings report [1] - The Q1 2025 performance suggests that Fresenius Medical Care is on a positive trajectory, potentially setting the stage for favorable results in the subsequent quarter [1]